BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 3893151)

  • 1. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.
    Willemze R; Scheffer E; Meijer CJ
    Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
    Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
    Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides.
    Bakels V; Van Oostveen JW; Geerts ML; Gordijn RL; Walboomers JM; Scheffer E; Meijer CJ; Willemze R
    J Pathol; 1993 Jul; 170(3):249-55. PubMed ID: 8133398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatopathic lymphadenopathy. An immunophenotypic comparison of cases associated and unassociated with mycosis fungoides.
    Burke JS; Sheibani K; Rappaport H
    Am J Pathol; 1986 May; 123(2):256-63. PubMed ID: 3486598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymph node localization of epidermotropic T malignant lymphomas (mycosis fungoides and Sézary's syndrome)].
    Wechsler J; Diebold J; Gérard-Marchant R
    Bull Cancer; 1984; 71(2):89-99. PubMed ID: 6610451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
    Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
    Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
    Thivolet J; Schmitt D; Souteyrand P; Brochier J
    Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymph node histopathologic aspects in cutaneous lymphomas of the mycosis fungoides or Sézary syndrome type. Retrospective study of 98 biopsies].
    Wechsler J; Diebold J; Gerard-Marchant R
    Ann Pathol; 1987; 7(2):122-9. PubMed ID: 3620027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
    Izban KF; Hsi ED; Alkan S
    Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexisting Hodgkin's disease and mycosis fungoides. Immunohistochemical proof of its existence.
    Simrell CR; Boccia RV; Longo DL; Jaffe ES
    Arch Pathol Lab Med; 1986 Nov; 110(11):1029-34. PubMed ID: 3096258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies.
    Schmitt D; Souteyrand P; Brochier J; Czernielewski J; Thivolet J
    Acta Derm Venereol; 1982; 62(3):193-9. PubMed ID: 6179357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycosis fungoides. Detection of OKT6+ cells by cytofluorographic analysis in one case.
    Cintorino M; del Vecchio MT; de' Santi MM; Lavarini E; Miracco C; Raffaelli M; Santopietro R; Leoncini L
    Am J Dermatopathol; 1987 Apr; 9(2):114-9. PubMed ID: 3509764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of cutaneous T-cell lymphomas.
    Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
    Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic morphometry of isolated lymph node cells from patients with mycosis fungoides and Sézary's syndrome.
    van der Loo EM; Cornelisse CJ; van Vloten WA; van der Velde EA; Scheffer E; Meijer CJ
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1980; 33(2):107-16. PubMed ID: 6109394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of monoclonal antibody HML-1-defined alpha E beta 7 integrin in cutaneous T cell lymphoma.
    Simonitsch I; Volc-Platzer B; Mosberger I; Radaszkiewicz T
    Am J Pathol; 1994 Nov; 145(5):1148-58. PubMed ID: 7977645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic differences between dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides.
    Weiss LM; Wood GS; Warnke RA
    Am J Pathol; 1985 Aug; 120(2):179-85. PubMed ID: 3161334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A; Dhungel BM; Khan MF
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.